SCHEMBL21841015

SCHEMBL21841015

COC1(Cl)C(=O)CC12CCN(C(=O)OC(C)(C)C)CC2

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
TSHR P16473 2/20 0.36
ALOX15 P16050 1/20 0.36
ATM Q13315 1/20 0.36
HPGD P15428 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
EPHX2 P34913 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP11B2 P19099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3240640 0.85 USP2 (0.44) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL25678641 0.83 USP2 (0.43) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL25678822 0.80 USP2 (0.45) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL15472728 0.80 CYP11B2 (0.41) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL22642600 0.79 USP2 (0.44) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL1966100 0.76 USP2 (0.50) USP2SMN1; SMN2MEN1KMT2ADDB1
SCHEMBL3612459 0.74 NR1H2 (0.42) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL6114979 0.73 NR1H2 (0.39) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL904136 0.72 USP2 (0.49) USP2SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL23797358 0.71 USP2 (0.45) USP2SMN1; SMN2TSHRALOX15ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768805-B1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS ORYZON GENOMICS SA (ES) 2020-03-25 EP disclosed